Skip to main content

Pro- und Präbiotika

  • Chapter

Zusammenfassung

Die rasante Entwicklung der Molekularbiologie und eine inzwischen beachtliche Fülle an Daten aus klinischen Studien haben in der vergangenen Dekade eine neue solide wissenschaftliche Basis für den Einsatz probiotischer Bakterien, speziell von Laktobazillen und Bifidobakterien ergeben. Entgegen manchen Postulierungen existiert jedoch ganz offenkundig sowohl in experimentellen als auch in klinischen Studien eine strenge Stammspezifik von Funktionen und Wirkungen dieser Spezies probiotischer Bakterien. Eine wissenschaftliche Rationale für die Nutzung von Laktobazillen und Bifidobakterien als Probiotika ist bisher nur für vergleichsweise wenige Stämme nachgewiesen worden. Dies gilt für lebende und hitzebehandelte Bakterien gleichermaßen, ob mit oder ohne Mitverwendung ihres Kulturüberstands in den Studienansätzen.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Deshpande G, Rao S, Patole S, Bulsara M (2010) Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125: 921–930

    Article  PubMed  Google Scholar 

  • Dimmitt RA, Staley EM, Chuang G et al. (2010) Role of postnatal acquisition of the intestinal microbiom in the early development of immune function. J Pediatr Gastroenterol Nutr 51: 262–273

    PubMed  CAS  Google Scholar 

  • FAO/WHO (2001) Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf. Zugegriffen: 19.07.21012

    Google Scholar 

  • Gionchetti P, Rizzello F, Venturi A et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305–309

    Article  PubMed  CAS  Google Scholar 

  • Goossens D, Jonkers D, Stobberingh E et al. (2003) Probiotics in gastroenterology: indications and future perspectives. Scand J Gastroenterol 239 (Suppl): 15–23

    Google Scholar 

  • Henker J, Müller S, Laass MW et al. (2008) Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol 46: 874–875

    Article  PubMed  CAS  Google Scholar 

  • Henker JHuynh HQ, Bruyn J de et al. (2009) Probiotic preparation (VSL#3) induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm Bowel Dis 15: 760–768

    Article  Google Scholar 

  • Köhler H, McGormic BA, Walker WA (2003) Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr 36: 175–185

    Article  PubMed  Google Scholar 

  • Kruis W, Fric P, Pokrotnieks J (2004). Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617–1623

    Article  PubMed  CAS  Google Scholar 

  • Kukkonen K, Savilahti E, Haahtela T et al. (2008) Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (symbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 122: 8–12

    Article  PubMed  Google Scholar 

  • Lin HC, Hsu CH, Chen HL et al. (2008) Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122: 693–700

    Article  PubMed  Google Scholar 

  • Marteau P, Seksik P, Jian R (2002) Probiotics and intestinal health effects: a clinical perspective. Br J Nutr 88 (Suppl 1): 51–57

    Article  Google Scholar 

  • Miele E, Pascarella F, Gianetti E et al. (2009) Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 104: 437–443

    Article  PubMed  CAS  Google Scholar 

  • Mohan R, Koebnick C, Schildt J et al. (2006) Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol 44: 4025–4031

    Article  PubMed  Google Scholar 

  • Niel CW van, Feudtner C, Garrison MM (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109: 678–684

    Article  PubMed  Google Scholar 

  • Otte J-M, Cario E, Podolsky DK (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054–1070

    Article  PubMed  CAS  Google Scholar 

  • Radke M (2010) Probiotika in der Kindergastroenterologie. Mschr Kinderheilk 158: 570–582

    Article  Google Scholar 

  • Reid G, Jass J, Sebulky MT, McGormick JK (2003) Potential use of probiotics in clinical practice. Clin Microbiol Rev 16: 658–672

    Article  PubMed  Google Scholar 

  • Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354: 635–639

    Article  PubMed  CAS  Google Scholar 

  • Schmelzle H, Wirth S, Skopnik H et al. (2003) Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high β-palmitic acid level, and nondigestible oligosaccharids. J Ped Gastroenterol Nutr 36: 343–351

    Article  CAS  Google Scholar 

  • Schwiertz A, Gruhl B, Löbnitz M et al. (2003) Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 54: 393–399

    Article  PubMed  Google Scholar 

  • Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28: 405–440

    Article  PubMed  CAS  Google Scholar 

  • Thomas DW, Greer FR, Committee on Nutrition, Section on Gastroenterology, Hepatology, and Nutrition (2010) Clinical report – probiotics and prebiotics in pediatrics. Pediatrics 126: 1217–1231

    Article  PubMed  Google Scholar 

  • Veereman-Wauters G, Staelens S, Broek H van de et al. (2011) Physiological and bifidogenic effects of prebiotic supplementation in infant formulae. J Pediatr Gastroenterol Nutr 52: 763–771

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Radke, M. (2013). Pro- und Präbiotika. In: Rodeck, B., Zimmer, KP. (eds) Pädiatrische Gastroenterologie, Hepatologie und Ernährung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24710-1_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-24710-1_30

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-24709-5

  • Online ISBN: 978-3-642-24710-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics